United States· US:75907-056_861cea42-b727-d539-2e5d-aa7de6629fd4
Dofetilide
A dofetilide product containing dofetilide, registered in United States by Dr. Reddy's Labratories Inc.. The same ATC class is registered in 3 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Dofetilide is registered in 3 of 19 countries.
Countries holding a registration under ATC C01BD04 (dofetilide), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 2 of them publish a price we can compare per daily dose
Dofetilide · ATC C01BD04
3 / 19 countries
- Finlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- DOFETILIDE
- Manufacturer
- Dr. Reddy's Labratories Inc.
- Country
- United States (US)
- ATC code
- C01BD04
- ATC class
- Dofetilide
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- August 9, 2026
Packs & prices · 2
- ndc1175907-056-60
- ndc11759070566060 CAPSULE in 1 BOTTLE, PLASTIC (75907-056-60)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
281 interactions on record for dofetilide.
Graded by severity as the source publishes them — 146 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Dofetilide · interactions on record
281 records
- 146 severe
- 78 moderate
- 9 minor
- 48 info
Most severe, free to view
- CimetidineA02BA01severe
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- OndansetronA04AA01severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Dofetilide in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ffce8aca-f23b-4777-8160-69819de1b35a GET /v1/drugs/ffce8aca-f23b-4777-8160-69819de1b35a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": ".125",
"substance": "DOFETILIDE",
"productndc": "75907-056",
"dosage_form": "CAPSULE",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "ANDA207058",
"marketing_category": "ANDA"
}See everything about dofetilide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.